Transgene Biotek Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 15, 2016, to transact the following business:<BR><BR>1. To take on record the unaudited financial results for the quarter ended December 31, 2015.<BR><BR>2. As per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, The Trading Window for transactions in shares of the Company is closed from February 01, 2016 to February 17, 2016 (both days inclusive), inter alia, for the purpose of announcement of the Un-audited Financial Results by the Company for the quarter ended on December 31, 2015.
|